HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prognostic factors of hematological recovery in life-threatening nonchemotherapy drug-induced agranulocytosis. A study of 91 patients from a single center.

AbstractOBJECTIVES:
We studied clinical factors that may influence the duration of hematological recovery to reach neutrophil counts and thus, indirectly, the prognosis in patients with life-threatening drug-induced agranulocytosis (DIA).
METHODS:
Using univariate and multivariate analyses with Cox's proportional hazard models, we determined the prognostic factors for hematological recovery, defined as neutrophil counts>0.5 and>1.5.10(9)/L, in 91 patients with established life-threatening DIA.
RESULTS:
Multivariable analysis showed that neutrophil count<0.1.10(9)/L (at diagnosis) and infection profile: severe infections or septic shock, adversely influenced the neutrophil recovery (for the two neutrophil levels). Hematopoietic growth factors were significantly associated with rapid hematological recovery (for the two neutrophil levels). Documented microbial infections and antiplatelet DIA were also associated with rapid hematological recovery (for a neutrophil count>1.5.10(9)/L).
CONCLUSION:
Our findings demonstrate that in life-threatening DIA, hematological recovery is mainly dependent of the neutrophil level, the type of infections and the utilization of hematopoietic growth factors.
AuthorsFréderic Maloisel, Emmanuel Andrès, Georges Kaltenbach, Esther Noel, Catherine Martin-Hunyadi, Patrick Dufour
JournalPresse medicale (Paris, France : 1983) (Presse Med) Vol. 33 Issue 17 Pg. 1164-8 (Oct 09 2004) ISSN: 0755-4982 [Print] France
PMID15523286 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Hematopoietic Cell Growth Factors
Topics
  • Acute Disease
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Agranulocytosis (chemically induced, pathology)
  • Female
  • Hematopoietic Cell Growth Factors (therapeutic use)
  • Humans
  • Infections (complications)
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Neutrophils
  • Prognosis
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: